S. Gu

A novel scoring system integrating molecular abnormalities with IPSS-R can improve the risk stratification in patients with MDS

Z. Ge, S. Gu, Jingya Xia, 2021, BMC cancer.

Mechanisms and Treatment Progress of Rituximab-Resistance in Diffuse Large B-cell Lymphoma.

W. Cho, S. Gu, G. Song, 2019, Current cancer drug targets.

Function of ALAS2 Gene in Congenital Sideroblastic Anemia

S. Gu, Jinghui Deng, Cho, 2019 .

The role of Capon in multiple myeloma

S. Gu, Hai-yan Liu, Hong Liu, 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Elevated TNFRSF4 gene expression is a predictor of poor prognosis in non-M3 acute myeloid leukemia

Z. Ge, Chunhua Song, Q. Han, 2020, Cancer Cell International.

Cryptic t(15;17) acute promyelocytic leukemia with a karyotype of add(11)(p15) and t(13;20) – A case report with a literature review

Z. Ge, S. Gu, J. Zi, 2020, Bosnian journal of basic medical sciences.

Targeting NAT10 Induces Apoptosis Associated With Enhancing Endoplasmic Reticulum Stress in Acute Myeloid Leukemia Cells

Z. Ge, Chunhua Song, Q. Han, 2020, Frontiers in Oncology.

Predictive value of FCGR3A genotype on response to rituximab induction and maintenance therapy (MT) in follicular non-Hodgkin's lymphoma (NHL).

G. Salles, M. Ghielmini, M. Fey, 2010 .